07:28 AM EDT, 09/09/2025 (MT Newswires) -- Eli Lilly ( LLY ) said Tuesday that it has launched Lilly TuneLab, the artificial intelligence and machine learning platform built on proprietary data obtained for more than $1 billion.

Lilly TuneLab is designed to provide biotech companies access to drug discovery models trained on Eli Lilly's ( LLY ) research data, according to the company. Eli Lilly ( LLY ) said the platform is part of its Lilly Catalyze360 suite of offerings, which covers strategic capital, laboratory facilities, and drug development.